Poniard Pharmaceuticals, Inc.
PARD
$0.0001
$0.000.00%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Net Income | 41.53% | 41.06% | 72.70% | 60.76% | 34.71% |
| Total Depreciation and Amortization | -4.89% | -3.35% | -3.29% | -5.81% | -7.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -22.19% | -29.15% |
| Total Other Non-Cash Items | -39.33% | -52.06% | -79.55% | -49.91% | -33.45% |
| Change in Net Operating Assets | 39.97% | 134.20% | 93.95% | -1,067.42% | 164.65% |
| Cash from Operations | 55.88% | 76.02% | 75.78% | 40.51% | 52.88% |
| Capital Expenditure | 100.00% | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -78.08% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | 98.17% | 241.21% | -34.61% |
| Cash from Investing | -100.00% | -100.03% | 92.55% | 241.47% | -34.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -588.57% | 0.00% |
| Issuance of Common Stock | -- | -- | -47.73% | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 0.00% | -- | 61.60% | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 95.06% | -6.57% | -216.88% | -24.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -309.06% | 24.96% | 224.46% | -213.80% | 86.96% |